BOPO — Biopower Operations Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- $2.63m
- $0.57m
Annual income statement for Biopower Operations, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2015 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.013 | 0 | 0 | 0.175 | 0.572 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.97 | 0 | 0 | 0.461 | 1.16 |
| Operating Profit | -1.96 | 0 | 0 | -0.286 | -0.592 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.21 | -0.13 | -0.13 | -0.441 | -0.793 |
| Net Income After Taxes | -2.21 | -0.13 | -0.13 | -0.441 | -0.793 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.21 | -0.13 | -0.13 | -0.441 | -0.793 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.21 | -0.13 | -0.13 | -0.441 | -0.793 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.053 | -0.003 | -0.003 | -0.01 | -0.017 |